Curanex Pharmaceuticals Inc Common Stock
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CURX research report →
About the company
Curanex Pharmaceuticals Inc. is an emerging biopharmaceutical company focused on identifying, advancing, and bringing to market plant-based medicines to address various inflammatory conditions. Their primary drug candidate, Phyto-N, is currently in development for a broad spectrum of health issues, including but not limited to ulcerative colitis, atopic dermatitis, COVID-19, diabetes, nonalcoholic fatty liver disease, gout, and acne.
- CEO
- Jun Liu
- IPO
- 2025
- Employees
- 6
- HQ
- Jericho, NY, US
Price Chart
- Market Cap
- $7.22M
- P/E
- -0.94
- P/S
- 0.00
- P/B
- 0.89
- EV/EBITDA
- -1.19
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -85.41%
- ROIC
- -86.83%
- Revenue
- $0 · 0.00%
- Net Income
- $-4,225,106 · -1068.75%
- EPS
- $-0.17 · -1207.69%
- Op Income
- $-4,239,076
- FCF YoY
- -1787.14%
- 52W High
- $9.18
- 52W Low
- $0.25
- 50D MA
- $0.33
- 200D MA
- $0.50
- Beta
- -2.85
- Avg Volume
- 98.08K
Get TickerSpark's AI analysis on CURX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Aug 25, 25 | Xie Liqin | other | 0 |
| Aug 25, 25 | Hsu Helen Hong | other | 0 |
| Aug 25, 25 | Zhong Huijuan | other | 0 |
| Aug 25, 25 | Yan Yong | other | 0 |
| Aug 25, 25 | Liu Jun | other | 0 |
| Aug 25, 25 | Liu Jun | other | 0 |
| Aug 25, 25 | Liu Jun | other | 0 |
| Aug 25, 25 | Liu Jun | other | 0 |
| Aug 25, 25 | Liu Jun | other | 0 |
| Aug 25, 25 | Hao Xiaohui | other | 0 |
Our CURX coverage
Recent articles, reports, and earnings notes.
No research on CURX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CURX report →Similar companies
Peers in the same neighborhood.